FDG PET or PET/CT in patients with pancreatic cancer: when does it add to diagnostic CT or MRI?
- PMID: 23465982
- DOI: 10.1016/j.clinimag.2012.07.005
FDG PET or PET/CT in patients with pancreatic cancer: when does it add to diagnostic CT or MRI?
Abstract
Objective: Assess the impact of FDG-PET or PET/CT (PI) on pancreatic cancer management when added to CT or MRI (CDI).
Materials and methods: Forty-nine patients underwent 79 PI exams. Discordant findings on PI and CDI were assessed for clinical impact.
Results: Fifteen of 79 PI-CDI pairs were discordant. Ten of 79 PI favorably and 5 of 79 unfavorably altered management. PI favorably altered management more often when ordered for therapy monitoring compared to staging [risk ratio 13.00 (95% CI 1.77-95.30)] or restaging [risk ratio 18.5 (95% CI 2.50-137.22)].
Conclusion: PI favorably alters management more often when used for therapy monitoring compared to staging or restaging.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa. Ann Surg. 2009. PMID: 19687736
-
Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8. Acta Gastroenterol Belg. 2007. PMID: 18330088
-
Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.Rev Esp Med Nucl Imagen Mol. 2014 May-Jun;33(3):159-64. doi: 10.1016/j.remn.2013.08.005. Epub 2013 Oct 17. Rev Esp Med Nucl Imagen Mol. 2014. PMID: 24140024
-
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.Eur J Surg Oncol. 2014 Jul;40(7):794-804. doi: 10.1016/j.ejso.2014.03.016. Epub 2014 Apr 3. Eur J Surg Oncol. 2014. PMID: 24755095 Review.
-
¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases.JOP. 2011 Nov 9;12(6):557-66. JOP. 2011. PMID: 22072244 Review.
Cited by
-
Selection criteria in resectable pancreatic cancer: a biological and morphological approach.World J Gastroenterol. 2014 Aug 28;20(32):11210-5. doi: 10.3748/wjg.v20.i32.11210. World J Gastroenterol. 2014. PMID: 25170205 Free PMC article. Review.
-
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Diagnostics (Basel). 2020 Dec 3;10(12):1042. doi: 10.3390/diagnostics10121042. Diagnostics (Basel). 2020. PMID: 33287195 Free PMC article. Review.
-
Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.PLoS One. 2019 Jan 10;14(1):e0210178. doi: 10.1371/journal.pone.0210178. eCollection 2019. PLoS One. 2019. PMID: 30629646 Free PMC article.
-
Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography.J Clin Med. 2021 Mar 10;10(6):1151. doi: 10.3390/jcm10061151. J Clin Med. 2021. PMID: 33801810 Free PMC article. Review.
-
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?Int J Mol Sci. 2021 Jun 15;22(12):6413. doi: 10.3390/ijms22126413. Int J Mol Sci. 2021. PMID: 34203923 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
